CG
TNGX icon

Caprock Group’s Tango Therapeutics TNGX Stock Holding History

Caprock Group’s Portfolio TNGX Stock Details TNGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$203K Buy
+6,504
New +$161K ﹤0.01% 1166

Other funds holding TNGX

CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
HP
HealthInvest Partners Stockholm, Sweden $372M AUM 59.89% 1-Year Est. Return
TE
Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return
DACS
Dymon Asia Capital (Singapore) Singapore $2.39B AUM 150.5% 1-Year Est. Return
PR
PSP Research Newtown Square, Pennsylvania $188M AUM
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Caprock Group's TNGX Position: Q2 2026 in Review

Caprock Group opened a new position in Tango Therapeutics (TNGX) in Q2 2026: 6,504 shares worth $203K. The stake represents ﹤0.01% of the portfolio and ranks #1166 among its holdings.

24 funds tracked by Wall St. Rank hold TNGX as of Q2 2026.

  • Caprock Group held 6,504 shares of Tango Therapeutics worth $203K as of Q2 2026.
  • Tango Therapeutics was a new Caprock Group position in Q2 2026.
  • Tango Therapeutics made up ﹤0.01% of Caprock Group's portfolio in Q2 2026, its #1166 holding.
  • 24 funds tracked by Wall St. Rank held Tango Therapeutics as of Q2 2026.

Based on Caprock Group's 13F filing for Q2 2026, filed 27 Jul 2026.